登录

Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.

Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn activates the target. Some targets respond directly to drugs by opening or closing ion channels. Others initiate a series of molecular events by coupling with downstream effectors to bring about a response.

Unlike agonists, antagonists bind to the target to inactivate them and inhibit the cellular response. Antagonists act by blocking the binding of agonists or endogenous ligands, suppressing target activity. Drugs compete with the endogenous ligand for the ligand binding site on the target. However, some drugs bind to alternative target sites called allosteric sites and act by either enhancing the binding of agonists to the target or blocking it. These drugs are also called allosteric activators and inhibitors.

The physical and chemical properties of drugs often influence their activity. For example, antacids usually contain salts of calcium, magnesium, and aluminum as active ingredients. Such alkaline compounds help neutralize gastric HCl, reducing the acid's corrosive effects on the lining of the esophagus and providing relief from acid reflux and heartburn.

Additionally, several recently approved biologics, such as genetically engineered enzymes, monoclonal antibodies, and genetically modified viruses and microbes, have been approved for therapeutic uses. An example of this is how a genetically modified live oncolytic herpes virus strain can be used to treat melanoma tumors left post-surgery.

Regardless of their mechanism of action, a drug needs to bind specifically to its target molecules to be a useful therapeutic tool. However, the drugs are only somewhat specific. As the concentration of the drug dose increases, the drug can bind to targets other than its actual target, causing various side effects such as inflammation or necrosis in epithelial and connective tissues. It is essential to focus on enhancing drug potency such that the drug is effective at a lower dose and has minimal side effects on the body.

Tags
Drug ActionPharmacodynamicsAgonistsAntagonistsReceptor BindingIon ChannelsTransportersEnzymesAllosteric SitesDrug PotencySide EffectsTherapeutic UsesBiologicsGenetically Engineered EnzymesMonoclonal AntibodiesOncolytic Virus

来自章节 4:

article

Now Playing

4.1 : Principles of Drug Action

Pharmacodynamics

5.5K Views

article

4.2 : 药物作用的目标:概述

Pharmacodynamics

5.2K Views

article

4.3 : 信号转导:概述

Pharmacodynamics

8.0K Views

article

4.4 : 换能器机制:G 蛋白偶联受体

Pharmacodynamics

1.6K Views

article

4.5 : 配体门控离子通道受体:门控机制

Pharmacodynamics

1.9K Views

article

4.6 : 换能器机制:酶联受体

Pharmacodynamics

2.2K Views

article

4.7 : 换能器机制:核受体

Pharmacodynamics

1.2K Views

article

4.8 : 剂量-反应关系:概述

Pharmacodynamics

2.7K Views

article

4.9 : 剂量-反应关系:效力和疗效

Pharmacodynamics

3.9K Views

article

4.10 : 剂量-反应关系:选择性和特异性

Pharmacodynamics

6.1K Views

article

4.11 : 治疗指数

Pharmacodynamics

3.8K Views

article

4.12 : 药物-受体相互作用:激动剂

Pharmacodynamics

2.2K Views

article

4.13 : 药物-受体相互作用:拮抗剂

Pharmacodynamics

2.4K Views

article

4.14 : 药物的综合作用:拮抗作用

Pharmacodynamics

7.5K Views

article

4.15 : 药物的综合作用:协同作用

Pharmacodynamics

3.0K Views

See More

JoVE Logo

政策

使用条款

隐私

科研

教育

关于 JoVE

版权所属 © 2025 MyJoVE 公司版权所有,本公司不涉及任何医疗业务和医疗服务。